Small Molecule Pharmaceuticals

 
 
Request Information

High-Quality Products and Services for Small Molecules


Developing a new pharmaceutical drug is a complex and challenging process. As the leader in high-quality products and services for the chemical and pharmaceutical industries, we offer everything you need to optimize development and reduce time to market for your therapeutic small molecules.

And with our comprehensive EMPROVE® dossiers we provide detailed, usage-specific documentation for more than 400 pharma raw materials that includes information on manufacturing, test methods, purity and stability data, helping you to successfully navigate regulatory challenges to the release of your small molecules.
  • A continually updated portfolio for evolving markets and regulatory requirements
  • A wide range of customer-centric services
  • Tailor-made production quantities on a global scale
  • Expertise and state-of-the-art equipment backed by a complete matrix of production technologies capable of fulfilling more than 95% of all common chemical reactions
  • Full service throughout the entire development chain supporting you in chemical as well as regulatory aspects
  • cGMP-certified and FDA-inspected development and production sites

News Releases

Sep 12, 2018
MilliporeSigma to Open China’s First Mobius® Single-use Manufacturing Facility in Wuxi

MilliporeSigma today announced the establishment of its first Mobius® Single-use Manufacturing Facility in China.

20180912
Oct 12, 2018
MilliporeSigma Recognized with CPhI Awards for Innovative Products

MilliporeSigma today announced that it has won two CPhI Pharma Awards for innovative products for the pharmaceutical industry.

20181012 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Oct 12, 2018
MilliporeSigma Recognized with CPhI Awards for Innovative Products

MilliporeSigma today announced that it has won two CPhI Pharma Awards for innovative products for the pharmaceutical industry.

20181012 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Nov 05, 2018
MilliporeSigma Launches BioContinuum™ Platform for Next-Generation Process Improvements

MilliporeSigma today launched its new BioContinuum™ Platform to advance biotherapeutic drug manufacturing through improved efficiency, simplified plant operations and greater quality and consistency.

20181105 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Nov 27, 2018
MilliporeSigma Wins Two R&D 100 Awards for Innovation in 2018

MilliporeSigma today announced that it has won two R&D 100 Awards.

20181127 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
View All News
 
Webinar:  API Stability in Solid Dose Formulation – the Myth of Inert Excipients

Webinar:
API Stability in Solid Dose Formulation – the Myth of Inert Excipients

Register Now
Successful Drug Development with Synthetic Lipids: Critical Aspects and Strategies

Webinar:
Successful Drug Development with Synthetic Lipids:
Critical Aspects and
Strategies

Watch Now
Webinar: Smart Labels - Digital Innovation by Raw Material Suppliers to Support Drug Manufacturers’ Processes

Webinar:
Smart Labels – Digital Innovation by Raw Material Suppliers to Support Drug Manufacturers’ Processes

Watch Now
Explore, Learn, Collaborate: M Lab® Collaboration Centers - Take a tour!

Events

Mar 19
03/19/19 - 03/23/19
DCAT Week
Omni Berkshire
New York, NY, USA
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing North America 20190319
Mar 12
03/12/19 - 03/13/19
IBC BioProcess International West
Santa Clara Convention Center
Santa Clara, CA, USA
Biopharmaceutical Manufacturing North America 20190312
Dec 11
12/11/18 - 12/13/18
Purification Experts Community Meeting
M Lab™ Collaboration Center
Molsheim, France
Biopharmaceutical Manufacturing Europe 20181211